Skip to content
Menu

Citigroup Maintains Buy on Bioage Labs, Lowers Price Target to $20

Benzinga Newsdesk 3 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Citigroup analyst Samantha Semenkow maintains Bioage Labs (NASDAQ:BIOA) with a Buy and lowers the price target from $21 to $20.

Citigroup analyst Samantha Semenkow maintains Bioage Labs (NASDAQ:BIOA) with a Buy and lowers the price target from $21 to $20.

Read at benzinga.com

← All stock news